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Introduction: Low grade fibromyxoid sarcoma is a distinctive variant of fibrosarcoma. We recently experienced a
rare case of low grade fibromyxoid sarcoma arising in the masseter muscle.
Case presentation: A 63-year-old Korean woman with a large growing mass in her right parotid gland area for 1 year
visited our clinic. Complete removal of the tumor was achieved by parotidectomy with facial nerve preservation.
The tumor measured over 4cm with pathologic findings compatible with low grade fibromyxoid sarcoma.
Conclusions: Low grade fibromyxoid sarcoma is an extremely rare tumor, and report of the present case is
noteworthy since it represents a rare localization of low grade fibromyxoid sarcoma in the head and neck. Close follow
up on a long-term basis is considered necessary because of its high potential to metastasize.
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Low grade fibromyxoid sarcoma is a cytologically bland
malignant neoplasm with alternating fibrous and myxoid
stroma of low grade and malignant potential [1]. Low
grade fibromyxoid sarcoma is considered a rare soft tis-
sue tumor with a high metastasizing potential, despite
its benign histologic appearance. Low grade fibromyxoid
sarcomas represent approximately 10% of soft tissue sar-
comas and are rarely found in the head and neck region.
The most common locations are the extremities, trunk,
chest and soft tissues.
There have been only five reported cases of low grade
fibromyxoid sarcoma in the head and neck [2]. Low grade
fibromyxoid sarcoma originating from the masseter muscle
has never been reported before. We recently experienced a
rare case of low grade fibromyxoid sarcoma in the mas-
seter muscle. Due to the relative rarity of low grade fibro-
myxoid sarcomas, there is no consensus regarding
treatment and postoperative follow-up recommendations.
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[3]. In order to detect possible metastasis in advance it is
important to inform the patients about the longstanding
metastatic potential of the disease and recommend pro-
longed follow-up.
Case presentation
A 63-year-old Korean woman who had no medical his-
tory presented with swelling at her right parotid gland
area that had persisted for 1 year. No abnormal findings
were found elsewhere, and the other laboratory tests
showed normal. A physical examination revealed a fixed
non-tender round-shaped mass at her right parotid
gland area. Images of neck computed tomography (CT)
revealed a 3.2cm-sized heterogeneously enhancing mass
which was located lateral to the mandibular rami and
next to her right masseter muscle (Fig. 1a, b). Neck
magnetic resonance imaging (MRI) showed a well-
demarcated, 2.5×3.0cm-sized, gadolinium-enhanced, and
fungating mass with internal hemorrhage and increased
vascularity (Fig. 1c, d). Ultrasonography showed a het-
erogeneous hypoechoic mass in her right parotid gland
suspicious for parotid gland tumor, and a fine-needle as-
piration biopsy showed a few fragments of relatively
short spindled cells in myxoid and bloody background.distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Axial (a) and coronal (b) images of neck computed tomography. The mass shows a heterogeneous density on right parotid gland, with no
erosion of adjacent structure. Axial (c) and coronal (d) images of neck magnetic resonance imaging. A 3.5×2.0cm-sized, irregular internal gadolinium-
enhanced mass can be seen between the right parotid area extending to masseter muscle. The lesion is relatively well demarcated with
smooth margins
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adenoma.
Superficial parotidectomy was done with modified
facelift incision. The main mass adjacent to her masseter
muscle was located at the anterior aspect of her parotid
gland (Fig. 2a). Pes anserinus and all branches of her fa-
cial nerve were identified and preserved (Fig. 2b, c). The
retrieved specimen revealed a 4cm-sized mass (Fig. 2d).
On macroscopic examination, the tumor was well-
demarcated and had a yellow-white appearance with
focal glistening areas on a cut section (Fig. 3a). On
microscopic examination, the tumor had alternating fi-
brous (cellular) and myxoid (hypocellular) areas (Fig. 3b).
The tumor cells were spindle and bland-looking with
rare mitosis (Fig. 3c, d). The histopathologic findings of
this tumor were compatible with low grade fibromyxoid
sarcoma. On postoperative examination, weakness of her
marginal facial nerve was noted; however, it was com-
pletely resolved on serial close follow up. She was disease-
free with no evidence of recurrence after 1-year follow up.
Discussion
Low grade fibromyxoid sarcoma was first described by
Evans in 1987 and is currently classified as a malignant
fibroblastic/myofibroblastic tumor by the World HealthOrganization [1]. These sarcomas typically affect mid-
adults and arise most commonly in the proximal ex-
tremities and trunk; however, low grade fibromyxoid sar-
comas can also arise at the head and neck region [2].
There are two reported cases which locally originated
from the glands of head and neck: one case from the thy-
roid gland and one case from the parotid gland, the latter
being a giant (12×8cm) primary low grade fibromyxoid sar-
coma originating from the parotid gland and being com-
pletely removed with sacrifice of the facial nerve [4, 5].
This is the first reported case of a low grade fibromyx-
oid sarcoma confined to the soft tissue of the masseter
muscle. The diagnosis of low grade fibromyxoid sarcoma
was confirmed by the characteristic histological appear-
ance with immunohistochemical staining [6, 7]. On
histological examination, low grade fibromyxoid sarcoma
shows alternating fibrous and myxoid areas. Also, the
surrounding cells are more crowded, round or ovoid,
and blend imperceptibly with the surrounding spindle-
shaped cells. On immunohistochemical examination, it
usually shows intense immunostaining for vimentin,
P53, bcl-2 and smooth muscle actin (SMA) and negative
for cytokeratin (CK)-19, galectin-3, and calcitonin; this
finding may help distinguish low grade fibromyxoid sar-
coma from other sarcomas [7, 8]. In the present case,
Fig. 3 Gross finding and histopathological view. The main mass showed well-margined shape (a). Cut section showed well-demarcated, yellow-
whitish mass with focal glistening area (b). Low power view showed tumor with alternating fibrous and myxoid areas on hematoxylin and eosin
×40 (c). High power view showed spindle tumor cells with minimal atypia on hematoxylin and eosin ×400 (d)
Fig. 2 Intraoperative findings. Communicating branch (white arrow) between marginal branch and buccal branch was noted and sacrificed to
remove complete mass excision (a). The main mass was located adjacent to masseter muscle in the deep lobe of parotid gland (b). All facial
nerve branches were preserved: temporal (T), zygomatic (Z), buccal (B), marginal mandibular (M), and cervical branches (C) (c). Gross finding of
main mass showed well-demarcated margin (d) margin (Supf. = superficial lobe of parotid gland, Main (Deep) = deep lobe of parotid gland)
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clusters and fragments of relatively bland-looking short
spindled cells in myxoid and bloody background. The
possibility of pleomorphic adenoma could not be ruled
out. However, histologic findings of hematoxylin and
eosin staining and immunohistochemistry were compat-
ible with those of low grade fibromyxoid sarcoma. The
main concern for differential diagnosis would be myxofi-
brosarcoma. Myxofibrosarcoma commonly arises in the
subcutaneous tissue of the elderly, while low grade fibro-
myxoid sarcoma typically arises in the skeletal muscle of
young patients. On histological examination, myxofibro-
sarcoma is uniformly myxoid and has a greater degree of
atypia than low grade fibromyxoid sarcoma.
Mucin 4 (MUC4) is a highly sensitive and specific im-
munostaining marker for low grade fibromyxoid sar-
coma [9]. In addition, low grade fibromyxoid sarcomas
have one of two distinct chromosomal translocations –
t(7;16)(q34;p11) or t(11;16)(p11;p11) – that results in the
fused in sarcoma (FUS)-CREB3L2 and FUS-CREB3L1
gene fusions [10]. Therefore, a specific immunostaining
marker such as FUS gene arrangement will also be use-
ful for diagnosing low grade fibromyxoid sarcomas.
However, generally, low grade fibromyxoid sarcomas can
be easily distinguished from other sarcomas on the basis
of histopathological findings. A fluorescent in situ
hybridization (FISH) probe and detection of specific im-
munostaining marker such as MUC4 would not be prac-
tical in terms of cost effectiveness. Therefore utilizing
FISH to detect a FUS gene rearrangement or MUC4
gene is an ancillary method for diagnosing low grade
fibromyxoid sarcomas.
Imaging features of low grade fibromyxoid sarcoma
are generally nonspecific [11]. Benign sarcomas are usu-
ally well encapsulated, whereas malignant sarcomas may
show extensive infiltration. Bone destruction can occur
secondary to pressure erosion and such a finding does
not necessarily indicate malignancy. In the present case,
a fungating mass with internal hemorrhage and in-
creased vascularity was noted on neck MRI, but these
findings were not specific for low grade fibromyxoid sar-
coma. In fact, preoperative imagings suggested the pres-
ence of a hemangioma rather than the low grade
fibromyxoid sarcoma. On intraoperative examination,
the tumor main mass was well marginated and complete
removal of the mass was relatively easy. Pathologically
enlarged lymph nodes were not identified in the oper-
ation field.
Complete surgical excision with a safety margin is the
mainstay of treatment for patients with low grade fibro-
myxoid sarcoma [3, 6]. The role of radiotherapy and
chemotherapy remains controversial; however, radiother-
apy has been indicated in cases in which the tumor can-
not be completely resected [3]. In the present case, wewere unable to predict the presence of a malignant
tumor on the basis of preoperative imaging studies, and
we planned complete surgical removal since the margins
were noted to be smooth and relatively clear. The surgi-
cal margins were defined according to the principles of
Enneking. Enneking et al. reported the 5-year overall
survival rate following surgery for low grade fibromyxoid
sarcoma is over 90%, with a more favorable prognosis
associated with smaller tumors [12]. Local recurrences
of low grade fibromyxoid sarcoma have been reported
from a few months to 15 years after initial treatment,
while distant spread has occurred from 0 to 45 years
after surgery. Radiotherapy or chemotherapy may be ne-
cessary for patients whose tumors recur locally or spread
to distant sites.
Low grade fibromyxoid sarcoma is a slow-growing
tumor, but this cancer has a tendency to recur. It has
been known to spread to distant organs many years after
surgery; therefore, close serial follow up on a long-term
basis would be required to prevent local or distant me-
tastasis due to the tendency to recur after initial
treatment.
Conclusions
This is the first report in the medical literature of a low
grade fibromyxoid sarcoma arising from the masseter
muscle. Although low grade fibromyxoid sarcoma has
the possibility of distant metastasis, it is likely that this
patient may have a favorable prognosis with long-term
close follow up because the tumor was solitary, well cap-
sulated, confined to the localized area, and did not show
severe mitosis in histology.
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